Treatment Type | Treatment Group (mg/kg) | n | Median Graft Survival (days) | Average Graft Survival (days) | Indefinite Graft Survival (% from group) | First Occurrence of Graft Failure (day from transplantation) |
---|---|---|---|---|---|---|
i.p. dose gradient | Untreated | 9 | 12 | 12.1 | 0 | 9 |
15 | 3 | 14 | 13.6 | 0 | 12 | |
30 | 13 | 17 | 29.6 | 15.3 | 7 | |
60 | 10 | 90 | 62.5 | 60 | 11 | |
120 | 5 | 48 | 54.6 | 40 | 18 | |
240 | 5 | 16 | 16.6 | 0 | 14 | |
i.p. dose distribution | 30/30 | 6 | 15 | 18.3 | 0 | 7 |
20/20/20 | 3 | 90 | 65.3 | 66.6 | 16 | |
s.c. | 60 | 6 | 90 | 77.1 | 83.3 | 13 |
30/30 | 5 | 20 | 31.4 | 20 | 11 | |
30 | 2 | 15 | 15 | 0 | 14 | |
15 | 1 | 17 | 17 | 0 | 17 | |
dynamic dose | 240→0 i.p. | 6 | 40 | 48.3 | 33.3 | 14 |
240→0 s.c. | 3 | 17 | 40.3 | 33.3 | 14 |